|
Professor
University of Rajshahi, Bangladesh
Tel: +8801521300098
Email: alimalbari347@ru.ac.bd
VALIDATE Role:
Network Affiliate
Research Keywords:
Host-Directed Therapy (HDT) Against MTB
Biography:
Dr. Al-Bari is currently engaged as Professor, Department of Pharmacy, University of Rajshahi, Bangladesh. He has finished his research work as a Postdoctoral fellow, Institute of Biophysics, Chinese Academy of Sciences, Beijing, China and as a Postdoctoral Professional Fellow, University of East London, Stratford Campus, United Kingdom. He also served as an Associate Professor and Assistant Professor in the Department of Pharmacy, University of Rajshahi, Bangladesh. He has obtained Ph.D. Degree in Department of Cell Signaling, Tokyo Medical and Dental University (TMDU), Japan since 2012. He has also supervised research activities of M. Pharm., M. Phil. and Ph.D. students. He was awarded with ‘Madar Bux Hall Gold Medal’ for securing first class in the B. Pharm. (Honours) Examination; ‘National Science & Information and Communication Technology (N.S.I.C.T) Fellowship’ (2002-2003) for new Streptomyces species; Japanese Government (Monbukagakusho: MEXT) Scholarship (2008-2012), and Advance I Super Student (AISS), GCOE Program of International Research Center for Molecular Science in Tooth and Bone Diseases, TMDU (2009-2012), Commonwealth Professional Fellowship (2016-2017) . He is an author for about 70 peer reviewed publications.
His Research Interests
- Pharmacological modulation of Autophagy
- Repurposing Drug Discovery (antibiotics)
- Cell Signalling
- Bone Biology
- Molecular Biology of Cells
Related Websites:
University of Rajshahi
LinkedIn
Key Publications:
- MAA Al-Bari, N Peake and N Eid (2024) Tuberculosis-diabetes comorbidities: Mechanistic insights for clinical considerations and treatment challenge. World Journal of Diabetes (Accepted)
- S Hossain, RH Rafi, FA Ripa, MRI Khan, ME Hosen, MKI Molla, MO Faruqe, MAA Al-Bari (2024) Modulating the antibacterial effect of the existing antibiotics along with repurposing drugs, Archives of Microbiology (Accepted)
- MAA Al-Bari, Menon MB, Eid N (2023) Editorial: Emerging mechanistic insights of selective and Nonselective Autophagy in liver and gut diseases and their treatment strategies in the era of COVID-19. Front. Pharmacol. 14:1206291. doi: 10.3389/fphar.2023.1206291.
- MA A Al-Bari, Ito Y, Thomes PG, Menon MB, García-Macia M, Fadel R, Stadlin A, Peake N, Faris ME, Eid N and Klionsky DJ (2023), Emerging mechanistic insights of selective autophagy in hepatic diseases. Front. Pharmacol. 14:1149809.doi: 10.3389/fphar.2023.1149809
- Al-Bari MAA (2022) Inhibition of autolysosomes by repurposing drugs as a promising therapeutic strategy for the treatment of cancers, All Life, 15:1, 568-601, DOI: 10.1080/26895293.2022.2078894
- MAA Al-Bari, Y Ito, S Ahmed, N Radwan, HS Ahmed, Eid N. Targeting autophagy with natural products as a potential therapeutic approach for cancer. Int J Mol Sci. 2021, 22, 9807. https://doi.org/10.3390/ijms22189807.
- DJ Klionsky, ……..MAA Al-Bari, ………….. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition). Autophagy. 2021 Jan;17(1):1-382. doi: 10.1080/15548627.2020.1797280.
- MAA Al-Bari, S Hossain, MKE Zahan. Exploration of sex-specific and age-dependent COVID-19 fatality rate in Bangladesh population. World Journal of Radiology. 2021 Jan 28;13(1):1-18. doi: 10.4329/wjr.v13.i1.1.
- MAA Al-Bari. Co-targeting of lysosome and mitophagy in cancer stem cells with chloroquine analogues and antibiotics. J Cell Mol Med. 2020 Oct;24(20):11667-11679. doi: 10.1111/jcmm.15879.
- MZ Islam, MKE Zahan, MAA Al-Bari. Convergence between global BCG vaccination and COVID-19 pandemic. J Med Virol. 2020 Aug 22;10.1002/jmv.26450. doi: 10.1002/jmv.26450.
|
